Skip to NavigationSkip to content

New COO for Celgene

Published on: 01/03/17

Celgene released in a statement that its Chief Operating Officer and President, Jacqualyn “Jackie” Fouse, will retire from her position. She will continue to fulfil her role until 1 April and continue to serve as strategic advisor beyond this period onto 1 June.

Fouse's role will be filled by Scott Smith, who takes the role after having launched Celgene’s Inflammation & Immunocology franchise and will take up the post immediately after Fouse vacates the role on 1 April. His position, in turn, will be filled by Terrie Curran – who will take the position of President, Global I&I Franchise.

Smith has been with Celgene for over 11 years, performing the roles of Senior Vice President of Immunology and the aforementione role. Prior this he had worked at Pfizer and Biovail.

"Scott is a tremendous leader with extensive industry experience and his teams have consistently delivered outstanding results," said Mark Alles, Celgene CEO. "Our entire organization will benefit from Scott's business expertise, strategic leadership, and focus on operational excellence."

Ben Hargreaves

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches